New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
CervoMed Inc.
CRVO
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

18M

Biotechnology

Next Earning date - 31 Mar 2025

18M

Biotechnology

Next Earning date - 31 Mar 2025

2.19USD

Shape-0.02 ( -0.90%)
Market Closed (as of Feb 10, 22:19 EDT)
favorite-chart

Relative Strenght

3
favorite-chart

Volume Buzz

-92%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

92%

Quote Panel

Shape
Updated February 11, 2025
1W -5.19 % 1M 7.35 % 3M -81.49 % 1Y -84.32 %

Key Metrics

Shape
  • Market Cap

    18.08M


  • Shares Outstanding

    8.25M


  • Share in Float

    5.35M


  • Dividende

    0


  • Earning Date

    31 Mar 2025


  • Price Target

    2.19


  • Average Volume

    449028


  • Beta

    0


  • Range

    1.8-26.38


  • Industry

    Biotechnology


  • Website

    https://www.cervomed.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

CRVO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$5M

ShapeNaN%

2025-Revenue

$1.64

Shape-197%

2025-EPS

$4M

Shape166%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

H.C. Wainwright

downgrade

Previous: Buy

2024-12-17

Now: Neutral

Morgan Stanley

downgrade

Previous: Overweight

2024-12-11

Now: Underweight

Chardan Capital

initialise

Previous: Not converted

2024-09-18

Now: Buy

Morgan Stanley

initialise

Previous: Not converted

2024-07-26

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

NA
vs -3.33

Q1.23

arrow
arrow

N/A

-3.01
vs NA

Q2.23

arrow
arrow

N/A

-1.04
vs -2.06

Q3.23

arrow
arrow

N/A

-0.70
vs -3.00

Q4.23

arrow
arrow

N/A

-0.38
vs NA

Q1.24

arrow
arrow

N/A

-0.41
vs -3.01

Q2.24

arrow
arrow

N/A

-0.27
vs -1.04

Q3.24

arrow
arrow

N/A

-0.55
vs -0.70

Q4.24

arrow
arrow

N/A

-0.62
vs -0.38

Q1.25

arrow
arrow

N/A

-0.58
vs -0.41

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

1.4M  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

1.5M  vs NA

Q4.23

arrow
arrow

NA

2.5M  vs NA

Q1.24

arrow
arrow

+67%

2.3M  vs 1.4M

Q2.24

arrow
arrow

NA

3.3M  vs NA

Q3.24

arrow
arrow

-100%

NA  vs 1.5M

Q4.24

arrow
arrow

-38%

1.5M  vs 2.5M

Q1.25

arrow
arrow

-44%

1.3M  vs 2.3M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-20%

-0.20
vs -0.12

Q1.23

arrow
arrow

-25%

-0.25
vs -0.20

Q2.23

arrow
arrow

-15%

-0.15
vs -0.25

Q3.23

arrow
arrow

+22%

0.22
vs -0.15

Q4.23

arrow
arrow

-32%

-0.32
vs 0.22

Q1.24

arrow
arrow

-47%

-0.47
vs -0.32

Q2.24

arrow
arrow

-5%

-0.05
vs -0.47

Q3.24

arrow
arrow

-10%

-0.10
vs -0.05

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News